English
✕
Youtube

Kopran Ltd.

₹227.45

Score

38

Technically Neutral

Technical

Kopran Price Change Analysis

Kopran Key Statistics

  • P/E Ratio

    47.2

  • PEG Ratio

    1.2

  • Market Cap Cr

    1096.6

  • Price to Book Ratio

    77.1

  • EPS

    4.9

  • Dividend

    30 ()

  • Relative Strength Index

    34.77

  • Money Flow Index

    52.31

  • MACD Signal

    -13.34

  • Average True Range

    17.38

Investment Ratings

  • Master Rating:

EPS Strength

Price Strength

Buyer Demand

Group Rank

Result Highlights

Kopran Synopsis

NSE-Medical-Diversified

Kopran Ltd is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 222.83 Cr. and Equity Capital is Rs. 43.25 Cr. for the Year ended 31/03/2021. Kopran Ltd. is a Public Limited Listed company incorporated on 26/04/1958 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1958PLC011078 and registration number is 011078.

  • Market Cap

    1,096.56

  • Sales

    201.98

  • Shares in Float

    2.70

  • No of Funds

    17

  • Yield

    0.66

  • Book Value

    3.99

  • U/D Vol Ratio

    1.1

  • LTDebt/Equity

    1

  • Alpha

    0.09

  • Beta

    1.19

Kopran Ownership
Kopran Management

Kopran Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Eps And Sales Estimates

Kopran Financials

  • Quarterly P&L
  • Annual P&L
  • Cash Flow
  • Balance Sheet
  • Ratios

Kopran Technicals

EMA & SMA

CURRENT PRICE

EMA

Kopran Resistance and Support

Kopran Delivery and Volume

Kopran Price Change Analysis

Corporate Action

MF Shareholding

Similar Stocks

News

FAQs

Kopran share price is

Open Demat Account